281 related articles for article (PubMed ID: 38090567)
21. Ultrasound targeted microbubble destruction-mediated SOCS3 attenuates biological characteristics and epithelial-mesenchymal transition (EMT) of breast cancer stem cells.
Tang X; Hao N; Zhou Y; Liu Y
Bioengineered; 2022 Feb; 13(2):3896-3910. PubMed ID: 35109743
[TBL] [Abstract][Full Text] [Related]
22. Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm.
Mannello F
BMC Med; 2013 Jul; 11():169. PubMed ID: 23879988
[TBL] [Abstract][Full Text] [Related]
23. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
[TBL] [Abstract][Full Text] [Related]
24. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.
Zhang R; Tu J; Liu S
Semin Cancer Biol; 2022 Jul; 82():11-25. PubMed ID: 33737107
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression.
Guo L; Zheng P; Fan H; Wang H; Xu W; Zhou W
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935760
[TBL] [Abstract][Full Text] [Related]
26. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
[TBL] [Abstract][Full Text] [Related]
28. Transcriptome sequencing of HER2-positive breast cancer stem cells identifies potential prognostic marker.
Lei B; Zhang XY; Zhou JP; Mu GN; Li YW; Zhang YX; Pang D
Tumour Biol; 2016 Nov; 37(11):14757-14764. PubMed ID: 27629143
[TBL] [Abstract][Full Text] [Related]
29. Brain infiltration of breast cancer stem cells is facilitated by paracrine signaling by inhibitor of differentiation 3 to nuclear respiratory factor 1.
Das JK; Deoraj A; Roy D; Felty Q
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2881-2891. PubMed ID: 35678885
[TBL] [Abstract][Full Text] [Related]
30. RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells.
Chen F; Gurler SB; Novo D; Selli C; Alferez DG; Eroglu S; Pavlou K; Zhang J; Sims AH; Humphreys NE; Adamson A; Campbell A; Sansom OJ; Tournier C; Clarke RB; Brennan K; Streuli CH; Ucar A
Oncogene; 2023 Feb; 42(9):679-692. PubMed ID: 36599922
[TBL] [Abstract][Full Text] [Related]
31. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer.
Wang C; Xu K; Wang R; Han X; Tang J; Guan X
J Exp Clin Cancer Res; 2021 Nov; 40(1):370. PubMed ID: 34801088
[TBL] [Abstract][Full Text] [Related]
33. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer stem cells.
Velasco-Velázquez MA; Homsi N; De La Fuente M; Pestell RG
Int J Biochem Cell Biol; 2012 Apr; 44(4):573-7. PubMed ID: 22249027
[TBL] [Abstract][Full Text] [Related]
36. Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2
Ly S; Anand V; El-Dana F; Nguyen K; Cai Y; Cai S; Piwnica-Worms H; Tripathy D; Sahin AA; Andreeff M; Battula VL
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33722905
[TBL] [Abstract][Full Text] [Related]
37. Three-Dimensional Manufactured Supports for Breast Cancer Stem Cell Population Characterization.
Polonio-Alcalá E; Rabionet M; Ruiz-Martínez S; Ciurana J; Puig T
Curr Drug Targets; 2019; 20(8):839-851. PubMed ID: 30465500
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome.
Sorrentino C; Ciummo SL; D'Antonio L; Fieni C; Lanuti P; Turdo A; Todaro M; Di Carlo E
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34663639
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological targets of breast cancer stem cells: a review.
Pindiprolu SKSS; Krishnamurthy PT; Chintamaneni PK
Naunyn Schmiedebergs Arch Pharmacol; 2018 May; 391(5):463-479. PubMed ID: 29476201
[TBL] [Abstract][Full Text] [Related]
40. Exploring the interplay between triple-negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies.
Zou Z; Luo T; Wang X; Wang B; Li Q
J Cell Physiol; 2024 May; ():. PubMed ID: 38807378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]